Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Carcinoma
Interventions: BIOLOGICAL: eftilagimod alpha|DRUG: Paclitaxel|OTHER: placebo
Sponsor: Immutep S.A.S.